Conflict of Interest Disclosure Form 2026
EAS Conflict of Interest Disclosure Policy The European Atherosclerosis Society (EAS) wishes to promote independence, objectivity, scientific rigor and a fair balance of representation, in all its activities.
The EAS have adopted a Conflict of Interest (COI) Disclosure Policy EAS recognizes that these relationships do not necessarily imply bias or decrease the value of participation in professional activities. Disclosure of these relationships is necessary for others to make an informed decision about the impact of the disclosed relationship. For instance, this may be relevant in the context of educational activities of the EAS. Those requested to complete the form below include: all EAS Officers and members of the Society’s Committees, members of EAS Consensus Position Paper expert panels or other publications with guidance on prevention of cardiovascular diseases, and EAS Congress and and EAS Course Organisers. The forms will be updated annually. The completed forms will be archived at the Society’s Administrative Offices and made accessible to EAS members on the Society’s website. Please disclose all relationships – current and previous – over the last three years (until today) relating to the health industry or other similar organisations/societies as described above. If you do not have any conflicts of interest to disclose, please check the appropriate box below.
You should not disclose any personal relationships due to personal or family medical care.
1. Equity interests Any ownership or entitlement to equity—such as stocks, stock options, or royalties—in a company, including income from patents or copyrights. This includes cases where you hold a controlling interest, represent the company, or significantly contribute to its business activities.
2. Director or employee Service as a director, medical officer or employment or engagement by a commercial organisation/ society, involved in the production, marketing, or distribution of products related to atherosclerosis treatment or research, whether or not remuneration is provided for such service.
3. Company Consultant Service as a consultant, paid or unpaid, by a commercial organisation involved in the production, marketing, or distribution of products related to atherosclerosis treatment or research, including roles on medical or scientific advisory boards, whether remuneration is provided.
4. Owner enterprise Sole ownership, partnership, or hold a principal role of a commercial enterprise that is involved in atherosclerosis treatment, research, or a related medical field.
5. Ownership of patent(s) Controlling interest in any patents related to atherosclerosis treatment, research, or a related medical field, or have you received royalties or other financial benefits from such patents.
6. Royalties Receipt of royalties, including for intellectual property, such as a device, drugs or a diagnostic tool. Extent of royalties received need not to be disclosed.
7. Company speaker honorarium Honoraria received for engagements at company sponsored meetings, events, conferences, seminars, or events, whether in person or virtual.
8. Trial participation Participation in clinical trials (as a professional), specifically those organized or supported by a company. Note that you should not include any clinical trials you have participated in as a non-professional (e.g. as a patient).
9. Participation in research financed by industry Involvement in research funded or facilitated by a company, including contributions to publications. Extent of research finances received need not to be disclosed.
10. Fellowship, travel grants and other support Financial or material support received, such as fellowships, travel grants, gifts, or in-kind donations, from entities with a commercial interest in atherosclerosis or related fields. This includes direct funding, travel allowances, or other benefits that may influence professional activities. Extent of such support received need not to be disclosed. Extent of such grants received need not to be disclosed.
11. Research grants Research grants, partial or full salary support from commercial organisation/society for self or employees for whom you are managerially responsible (i.e. laboratory technical/research fellows). This also includes funding for projects in the field of atherosclerosis or other medical research areas that may overlap with the objectives of the European Atherosclerosis Society (EAS). Extent of such grants received need not to be disclosed.
12. Other societies /organisations – leadership roles Leadership roles in societies/organisations that may intersect with or compete against EAS’s objectives.
13. Publications Any scientific publications co-authored with individuals or representatives from non-academic organisations, such as companies or industry partners. List the articles.
14. Family member disclosure Immediate family members (such as spouse, children, or parents) involved in any of the situations mentioned above. Note that no personal data should be provided; only relevant relationships and affiliations should be disclosed.
15. Other Other types of financial or other relationship to the health industry. Note that you should not include any information that could relate to your political opinion, philosophical belief or your personal health.
Should any changes occur concerning my financial interests or positions of influence which might impact my EAS activities during the current year, I will promptly advise the EAS Office at [email protected] .
I assume full responsibility for identifying any potential conflicts of interest and I am aware that I can be excluded from the EAS in case of inaccurate declaration. I am aware that my declarations of interest will be made public in the framework defined in the EAS Conflict of Interest Disclosure Policy terms.
Information about our processing of your personal data: We, European Atherosclerosis Society (EAS), will process your personal data when you fill out this Conflict of Interest Disclosure Form and when we publish it on our web-site. We process your personal data to ensure that there are no conflicts of interest when you participate in the organization of activities on behalf of the EAS Society. For this purpose, and in order for our members to have relevant information about your potential interests, your personal data provided in this form will be published on our member-site.
EAS (Swedish company registration number 802418-0427) is the controller for such processing of your personal data. If you want to object to our processing of your personal data or ask questions regarding how we process your personal data, you can contact us via email at [email protected] or call us at +46 (0) 31 760 24 27. For more information on how we process your personal data and your rights, please see our Privacy Policy.
Next
